VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,736,000 | +32.2% | 84,730 | +47.4% | 0.13% | +0.8% |
| Q4 2020 | $2,070,000 | -7.6% | 57,471 | +0.5% | 0.12% | -16.1% |
| Q3 2020 | $2,240,000 | +0.7% | 57,198 | -5.7% | 0.15% | -3.9% |
| Q2 2020 | $2,224,000 | -73.9% | 60,634 | -83.6% | 0.16% | -81.1% |
| Q1 2020 | $8,527,000 | -68.2% | 370,111 | -59.6% | 0.82% | -54.7% |
| Q4 2019 | $26,849,000 | +11.6% | 916,970 | +1.8% | 1.81% | +7.8% |
| Q3 2019 | $24,057,000 | -19.1% | 900,668 | -22.6% | 1.68% | -18.6% |
| Q2 2019 | $29,754,000 | +11.0% | 1,164,068 | -2.6% | 2.06% | +9.8% |
| Q1 2019 | $26,797,000 | +2598.6% | 1,195,215 | +2438.9% | 1.88% | +2435.1% |
| Q4 2018 | $993,000 | +11.6% | 47,076 | -2.1% | 0.07% | +21.3% |
| Q3 2018 | $890,000 | -4.7% | 48,074 | +14.8% | 0.06% | +8.9% |
| Q2 2018 | $934,000 | -21.2% | 41,886 | -22.3% | 0.06% | -20.0% |
| Q1 2018 | $1,185,000 | – | 53,935 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |